Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Terminated
1(14%)

Phase Distribution

Ph not_applicable
3
43%
Ph phase_4
1
14%
Ph phase_1
2
29%

Phase Distribution

2

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
2(33.3%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
3(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(2)
Terminated(2)
Other(3)

Detailed Status

unknown3
Completed2
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (33.3%)
Phase 41 (16.7%)
N/A3 (50.0%)

Trials by Status

completed229%
terminated114%
unknown343%
withdrawn114%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
PROCEDURE
Total Trials
7